EMPIRE10 (Evaluation of Methods for Pulmonary Image REgistration 2010) is a public platform for fair and meaningful comparison of registration algorithms which are applied to a database of intrapatient thoracic CT image pairs. Evaluation of nonrigid registration techniques is a nontrivial task. This is compounded by the fact that researchers typically test only on their own data, which varies widely. For this reason, reliable assessment and comparison of different registration algorithms has been virtually impossible in the past. In this work we present the results of the launch phase of EMPIRE10, which comprised the comprehensive evaluation and comparison of 20 individual algorithms from leading academic and industrial research groups. All algorithms are applied to the same set of 30 thoracic CT pairs. Algorithm settings and parameters are chosen by researchers expert in the configuration of their own method and the evaluation is independent, using the same criteria for all participants. All results are published on the EMPIRE10 website (http://empire10.isi.uu.nl). The challenge remains ongoing and open to new participants. Full results from 24 algorithms have been published at the time of writing. This paper details the organization of the challenge, the data and evaluation methods and the outcome of the initial launch with 20 algorithms. The gain in knowledge and future work are discussed.
The IBIS platform is a validated system that allows researchers to quickly bring the results of their work into the operating room for evaluation. It is the first open-source navigation system to provide a complete solution for AR visualization.
BACKGROUND AND PURPOSE: Our aims were the following: 1) to compare multicontrast cortical lesion detection using 3T and 7T MR imaging, 2) to compare cortical lesion type frequency in relapsing-remitting and secondary-progressive MS, and 3) to assess whether detectability is related to the magnetization transfer ratio, an imaging marker sensitive to myelin content. MATERIALS AND METHODS: Multicontrast 3T and 7T MR images from 10 participants with relapsing-remitting MS and 10 with secondaryprogressive MS. We used the following 3T contrast sequences: 3D-T1-weighted, quantitative T1, FLAIR, magnetization-transfer, and 2D proton-density-and T2-weighted. We used the following 7T contrast sequences: 3D-T1-weighted, quantitative T1, and 2D-T2 *-weighted. RESULTS: Cortical lesion counts at 7T were the following: 720 total cortical lesions, 420 leukocortical lesions (58%), 27 intracortical lesions (4%), and 273 subpial lesions (38%). Cortical lesion counts at 3T were the following: 424 total cortical, 393 leukocortical (93%), zero intracortical, and 31 subpial (7%) lesions. Total, intracortical, and subpial 3T lesion counts were significantly lower than the 7T counts (P Ͻ .002). Leukocortical lesion counts were not significantly different between scanners. Total and leukocortical lesion counts were significantly higher in secondary-progressive MS, at 3T and 7T (P Յ .02). Subpial lesions were significantly higher in secondary-progressive MS at 7T (P ϭ .006). The magnetization transfer ratio values of leukocortical lesions visible on both scanners were significantly lower than the magnetization transfer ratio values of leukocortical lesions visible only at 3T. No significant difference was found in magnetization transfer ratio values between subpial lesions visible only at 7T and subpial lesions visible on both 3T and 7T. CONCLUSIONS: Detection of leukocortical lesions at 3T is comparable with that at 7T MR imaging. Imaging at 3T is less sensitive to intracortical and subpial lesions. Leukocortical lesions not visible on 7T T2*-weighted MRI may be associated with less demyelination than those that are visible. Detectability of subpial lesions does not appear to be related to the degree of demyelination. ABBREVIATIONS: CL ϭ cortical lesion; IC ϭ intracortical; LC ϭ leukocortical; MTR ϭ magnetization transfer ratio; NAcGM ϭ normal-appearing cortical GM; RRMS ϭ relapsing-remitting MS; SP ϭ subpial; SPMS ϭ secondary-progressive MS M ultiple sclerosis is an inflammatory and neurodegenerative disease characterized by lesions that affect the white matter and gray matter of the central nervous system. 1 MR imaging of the brain is the criterion standard method to detect MS lesions in vivo, 2 allowing an accurate quantification of the WM component of MS. However, correlations between a patient's clinical status and WM lesion load remain modest 3,4 , so it is
In this paper, we propose a new multi-scale technique for multi-modal image registration based on the alignment of selected gradient orientations of reduced uncertainty. We show how the registration robustness and accuracy can be improved by restricting the evaluation of gradient orientation alignment to locations where the uncertainty of fixed image gradient orientations is minimal, which we formally demonstrate correspond to locations of high gradient magnitude. We also embed a computationally efficient technique for estimating the gradient orientations of the transformed moving image (rather than resampling pixel intensities and recomputing image gradients). We have applied our method to different rigid multi-modal registration contexts. Our approach outperforms mutual information and other competing metrics in the context of rigid multi-modal brain registration, where we show sub-millimeter accuracy with cases obtained from the retrospective image registration evaluation project. Furthermore, our approach shows significant improvements over standard methods in the highly challenging clinical context of image guided neurosurgery, where we demonstrate misregistration of less than 2 mm with relation to expert selected landmarks for the registration of pre-operative brain magnetic resonance images to intra-operative ultrasound images.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.